Track Teva Pharmaceutical Industries Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Teva Pharmaceutical Industries Limited TEVA · Stock Open Teva Pharmaceutical Industries Limited in new tab

38.61 USD
Add to portfolio
P/E
61.82
EPS
0.60
P/B
5.57
ROE
9.69
Beta
0.87
Target Price
41.91 USD
Teva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited

🧾 Earnings Recap – Q3 2025

Teva Pharmaceutical Industries reported robust growth in Q3 2025, achieving its 11th consecutive quarter of revenue increase, with total revenue up 3% year-over-year and adjusted EBITDA rising 6%.

  • Revenue reached $4.5 billion, driven by a 33% increase in innovative product sales, totaling over $800 million.
  • AUSTEDO's revenue grew 38% year-over-year, surpassing $600 million for the first time, and reaffirmed a 2027 revenue target of $2.5 billion.
  • UZEDY experienced a 24% revenue increase with a 119% rise in TRx, confirming long-term peak sales ambitions of $1.5 billion to $2 billion.
  • Free cash flow exceeded $0.5 billion, and net debt to EBITDA improved to below 3x, marking a significant financial milestone for the firm.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 4, 2026
P/E61.82
EPS0.60
Book Value6.65
Price to Book5.57
Debt/Equity217.79
% Insiders0.004%
Growth
Revenue Growth-0.01%
Earnings Growth0.72%
Estimates
Forward P/E12.08
Forward EPS3.07
Target Mean Price41.91

DCF Valuation

Tweak assumptions to recompute fair value for Teva Pharmaceutical Industries Limited (TEVA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Teva Pharmaceutical Industries Limited Logo Teva Pharmaceutical Industries Limited Analysis (TEVA)

Israel Health Care Official Website Stock

Is Teva Pharmaceutical Industries Limited a good investment? Teva Pharmaceutical Industries Limited (TEVA) is currently trading at 38.61 USD. Market analysts have a consensus price target of 41.91 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 61.82. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Teva Pharmaceutical Industries Limited is expected to release its next earnings report on Nov. 4, 2026. The market consensus estimate for Forward EPS is 3.07.

Investor FAQ

Does Teva Pharmaceutical Industries Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 4, 2026. The company currently has a trailing EPS of 0.60.

Company Profile

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Exchange Ticker
NYQ (United States) TEVA
FRA (Germany) TEV.F
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2017
0.85 USD
Dec. 12, 2017 0.0850
Sept. 14, 2017 0.0850
June 22, 2017 0.3400
March 20, 2017 0.3400
▸2016
1.36 USD
Dec. 20, 2016 0.3400
Sept. 8, 2016 0.3400
June 7, 2016 0.3400
March 14, 2016 0.3400
▸2015
1.36 USD
Dec. 3, 2015 0.3400
Sept. 3, 2015 0.3400
June 4, 2015 0.3400
March 3, 2015 0.3400
▸2014
1.37 USD
Dec. 2, 2014 0.3210
Sept. 4, 2014 0.3530
June 2, 2014 0.3470
March 10, 2014 0.3450
▸2013
1.28 USD
Dec. 3, 2013 0.3260
Sept. 3, 2013 0.3220
June 3, 2013 0.3200
March 7, 2013 0.3100
▸2012
1.03 USD
Dec. 3, 2012 0.2570
Sept. 4, 2012 0.2490
June 4, 2012 0.2610
Feb. 23, 2012 0.2670
▸2011
0.90 USD
Dec. 7, 2011 0.2190
Aug. 25, 2011 0.2350
June 7, 2011 0.2320
March 7, 2011 0.2150
▸2010
0.75 USD
Dec. 6, 2010 0.1930
Aug. 26, 2010 0.1810
May 10, 2010 0.1880
Feb. 19, 2010 0.1860
▸2009
0.61 USD
Nov. 6, 2009 0.1580
Aug. 3, 2009 0.1540
May 8, 2009 0.1450
Feb. 23, 2009 0.1480
▸2008
0.50 USD
Nov. 7, 2008 0.1170
Aug. 1, 2008 0.1300
May 13, 2008 0.1310
Feb. 15, 2008 0.1250
▸2007
0.39 USD
Nov. 2, 2007 0.1010
Aug. 10, 2007 0.0920
May 10, 2007 0.0980
Feb. 16, 2007 0.0940
▸2006
0.31 USD
Nov. 10, 2006 0.0790
Aug. 11, 2006 0.0780
May 12, 2006 0.0770
March 6, 2006 0.0720
▸2005
0.27 USD
Nov. 10, 2005 0.0640
Aug. 11, 2005 0.0670
May 5, 2005 0.0690
Feb. 17, 2005 0.0690
▸2004
0.30 USD
Nov. 9, 2004 0.0510
Aug. 9, 2004 0.0500
May 10, 2004 0.0980
Feb. 20, 2004 0.1010
▸2003
0.32 USD
Nov. 13, 2003 0.0730
Aug. 8, 2003 0.0750
May 8, 2003 0.0740
Feb. 24, 2003 0.0680
Jan. 7, 2003 0.0350
▸2002
0.45 USD
Nov. 7, 2002 0.0225
Nov. 7, 2002 0.0900
Aug. 19, 2002 0.0228
Aug. 19, 2002 0.0910
May 20, 2002 0.0880
May 20, 2002 0.0220
Feb. 15, 2002 0.0930
Feb. 15, 2002 0.0233
▸2001
0.32 USD
Nov. 16, 2001 0.0160
Nov. 16, 2001 0.0640
Aug. 20, 2001 0.0160
Aug. 20, 2001 0.0640
May 17, 2001 0.0163
May 17, 2001 0.0650
March 8, 2001 0.0165
March 8, 2001 0.0660
▸2000
0.21 USD
Nov. 16, 2000 0.0550
Nov. 16, 2000 0.0138
Aug. 24, 2000 0.0140
Aug. 24, 2000 0.0560
May 19, 2000 0.0135
May 19, 2000 0.0540
▸1999
0.25 USD
Nov. 4, 1999 0.0066
Nov. 4, 1999 0.0530
Aug. 18, 1999 0.0550
Aug. 18, 1999 0.0069
May 21, 1999 0.0069
May 21, 1999 0.0550
March 8, 1999 0.0580
March 8, 1999 0.0073
▸1998
0.31 USD
Dec. 11, 1998 0.0081
Dec. 11, 1998 0.0700
Nov. 16, 1998 0.0081
Aug. 21, 1998 0.0650
Aug. 21, 1998 0.0081
May 21, 1998 0.0650
May 21, 1998 0.0081
March 12, 1998 0.0680
March 12, 1998 0.0085
▸1997
0.28 USD
Nov. 20, 1997 0.0085
Nov. 20, 1997 0.0680
Aug. 25, 1997 0.0085
Aug. 25, 1997 0.0680
May 23, 1997 0.0075
May 23, 1997 0.0600
March 7, 1997 0.0520
March 7, 1997 0.0065
▸1996
0.23 USD
Nov. 20, 1996 0.0063
Nov. 20, 1996 0.0500
Aug. 26, 1996 0.0500
Aug. 26, 1996 0.0063
May 23, 1996 0.0500
May 23, 1996 0.0063
March 7, 1996 0.0500
March 7, 1996 0.0063
▸1995
0.24 USD
Nov. 20, 1995 0.0063
Nov. 20, 1995 0.0500
Aug. 14, 1995 0.0063
Aug. 14, 1995 0.0500
May 17, 1995 0.0650
May 17, 1995 0.0081
March 7, 1995 0.0520
March 7, 1995 0.0065
▸1994
0.16 USD
Nov. 15, 1994 0.0480
Nov. 15, 1994 0.0060
Aug. 9, 1994 0.0500
Aug. 9, 1994 0.0063
March 8, 1994 0.0053
March 8, 1994 0.0420
▸1993
0.17 USD
Nov. 17, 1993 0.0370
Nov. 17, 1993 0.0046
Aug. 17, 1993 0.0370
Aug. 17, 1993 0.0046
May 18, 1993 0.0044
May 18, 1993 0.0350
April 7, 1993 0.0400
April 7, 1993 0.0025
▸1992
0.18 USD
Nov. 17, 1992 0.0400
Nov. 17, 1992 0.0025
Aug. 18, 1992 0.0031
Aug. 18, 1992 0.0500
May 19, 1992 0.0026
May 19, 1992 0.0420
March 3, 1992 0.0350
March 3, 1992 0.0022
▸1991
0.16 USD
Nov. 20, 1991 0.0350
Nov. 20, 1991 0.0022
Aug. 21, 1991 0.0022
Aug. 21, 1991 0.0350
May 20, 1991 0.0025
May 20, 1991 0.0400
March 5, 1991 0.0400
March 5, 1991 0.0025
▸1990
0.16 USD
Nov. 20, 1990 0.0023
Nov. 20, 1990 0.0370
Aug. 17, 1990 0.0370
Aug. 17, 1990 0.0023
May 21, 1990 0.0350
May 21, 1990 0.0022
March 8, 1990 0.0380
March 8, 1990 0.0024
▸1989
0.14 USD
Nov. 20, 1989 0.0310
Nov. 20, 1989 0.0019
Aug. 16, 1989 0.0019
Aug. 16, 1989 0.0300
May 22, 1989 0.0019
May 22, 1989 0.0310
March 9, 1989 0.0370
March 9, 1989 0.0023
▸1988
0.16 USD
Dec. 6, 1988 0.0019
Dec. 6, 1988 0.0300
Sept. 8, 1988 0.0360
Sept. 8, 1988 0.0023
June 10, 1988 0.0280
June 10, 1988 0.0018
April 12, 1988 0.0300
April 12, 1988 0.0019
Feb. 8, 1988 0.0019
Feb. 8, 1988 0.0300
▸1987
0.14 USD
Oct. 23, 1987 0.0019
Oct. 23, 1987 0.0300
July 9, 1987 0.0024
July 9, 1987 0.0380
June 22, 1987 0.0019
June 22, 1987 0.0300
Feb. 23, 1987 0.0300
Feb. 23, 1987 0.0019
Stock Splits
Split Date Split Ratio to 1
Aug. 16, 1982 1.4
April 14, 1993 2:1
Feb. 23, 2000 2:1
Dec. 6, 2002 2:1
July 1, 2004 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion